Filing Flows

Filing Flows › Comparisons › TNDM vs IRTC

Tandem Diabetes Care vs iRhythm Holdings: TNDM and IRTC compared

Tandem Diabetes Care is the larger company: $284M of revenue in its latest quarter (Q3 2026) against $222M for iRhythm Holdings (Q3 2026). iRhythm Holdings is growing faster (+15% against +14% a year earlier). Tandem Diabetes Care is more profitable, with an operating margin of -0.8% against -14.7%.

Tandem Diabetes Care vs iRhythm Holdings, latest quarterTandem Diabetes Care vs iRhythm Holdings, latest quarterTandem Diabetes Care (TNDM)iRhythm Holdings (IRTC)Revenue$284M$222MRevenue growth, Y/Y+14%+15%Operating margin-0.8%-14.7%Net margin-2.5%-13.5%

Where the money goes: TNDM and IRTC

Tandem Diabetes Care (TNDM) · Q3 2026

Tandem Diabetes Care, Q3 2026: revenue $284M (+14% year over year), operating margin -0.8%, net loss $7.1M, operating cash flow −$819K. The chart follows the revenue to costs, profit and cash.

iRhythm Holdings (IRTC) · Q3 2026

iRhythm Holdings, Q3 2026: revenue $222M (+15% year over year), operating margin -14.7%, net loss $29.9M, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.

Tandem Diabetes Care revenue by segment, Q3 2026Tandem Diabetes Care revenue by segment, Q3 2026Supplies and other$169MPump$115M
iRhythm Holdings revenue by segment, Q3 2026iRhythm Holdings revenue by segment, Q3 2026Contracted third-party payors$111MCMS$57.2MCustomer A$37.4MNon-contracted third-party payors$16.1M
Tandem Diabetes Care (TNDM)iRhythm Holdings (IRTC)
Latest quarterQ3 2026Q3 2026
Revenue$284M$222M
Revenue growth, Y/Y+14%+15%
Operating margin-0.8%-14.7%
Net earnings−$7.1M−$29.9M
Net margin-2.5%-13.5%
Operating cash flow−$819K$4.4M
Market value$1.2B—
Analysts’ mean target$27.57—

Where the revenue comes from

Tandem Diabetes Care

iRhythm Holdings

Questions

Which is bigger, Tandem Diabetes Care or iRhythm Holdings?

Tandem Diabetes Care is the larger company: $284M of revenue in its latest quarter (Q3 2026) against $222M for iRhythm Holdings (Q3 2026).

Is Tandem Diabetes Care or iRhythm Holdings growing faster?

iRhythm Holdings is growing faster (+15% against +14% a year earlier).

Which is more profitable, Tandem Diabetes Care or iRhythm Holdings?

Tandem Diabetes Care is more profitable, with an operating margin of -0.8% against -14.7%.

More: Tandem Diabetes Care earnings · how Tandem Diabetes Care makes money · iRhythm Holdings earnings · how iRhythm Holdings makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.